# A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.

> **NCT01889745** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Biotoxtech Co., Ltd**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HX-1171

## Key facts

- **NCT ID:** NCT01889745
- **Lead sponsor:** Biotoxtech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889745, "A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01889745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*